Psychiatric Medication Augmentation Strategies in Personal Injury

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 9 min read

Augmentation therapy -- adding a second medication to enhance the effect of a primary psychiatric agent -- is a common and clinically necessary strategy in personal injury cases where single-agent treatment provides incomplete symptom relief. Understanding augmentation rationale helps attorneys recognize why multi-medication regimens document injury severity rather than overtreatment.

Augmentation therapy in psychiatric pharmacotherapy means adding a second medication to enhance the effect of a primary agent that provides incomplete symptom relief. In personal injury cases, augmentation is common because the psychiatric conditions caused by trauma -- PTSD, generalized anxiety, depression, insomnia -- frequently overlap and resist single-agent treatment. Understanding why augmentation is necessary helps attorneys explain multi-medication regimens as evidence of injury severity.

• Augmentation adds a second agent to enhance partial response from a primary medication, not to replace it
• Common augmentation strategies include SSRI + buspirone for anxiety, SSRI + prazosin for nightmares, and SSRI + trazodone for insomnia
• Each augmentation step documents a clinical determination that the patient's condition requires more aggressive treatment
• LienScripts covers all augmentation medications under a pharmacy lien at zero upfront cost
• Multi-agent regimens are standard psychiatric practice, not evidence of overtreatment

Why Augmentation Is Necessary in PI Cases

Personal injury patients face a unique psychiatric treatment challenge: the conditions caused by their accident -- anxiety, PTSD, depression, insomnia, pain -- share neural pathways and exacerbate each other. An SSRI prescribed for PTSD may partially control re-experiencing symptoms but leave nightmares, insomnia, and hyperarousal inadequately managed. A single agent rarely addresses the full symptom burden of a multi-system psychiatric injury.

Augmentation is the standard-of-care response to partial treatment response. It is not polypharmacy in the pejorative sense -- it is targeted, mechanism-based addition of agents that address specific uncontrolled symptom clusters.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist with clinical experience in psychiatric pharmacy, explains: "Every augmentation step in a PI patient's medication record tells a story. The physician tried the first-line agent, achieved partial response, and determined that an additional medication was clinically necessary to control a specific symptom cluster. This is not overtreatment -- it is the natural progression of managing complex trauma-related psychiatric conditions."

Common Augmentation Strategies

SSRI + Buspirone (Anxiety Augmentation)

When an SSRI (sertraline, escitalopram) provides partial anxiety relief, buspirone 15-60 mg daily enhances anxiolytic effect through a complementary mechanism -- 5-HT1A partial agonism vs. serotonin reuptake inhibition. This is one of the best-studied augmentation strategies in anxiety management.

SSRI + Prazosin (Nightmare Augmentation)

SSRIs reduce overall PTSD symptom burden but frequently leave nightmares inadequately controlled. Prazosin 1-15 mg at bedtime specifically targets trauma nightmares through alpha-1 adrenergic blockade -- a mechanism entirely independent of serotonergic modulation. The addition of prazosin documents the specific presence of trauma nightmares.

SSRI + Trazodone (Insomnia Augmentation)

Trazodone 25-100 mg at bedtime addresses the insomnia component that SSRIs may not resolve -- and that SSRIs themselves can sometimes worsen. Trazodone's 5-HT2A antagonism and histamine blockade provide sleep promotion through pathways independent of the SSRI's reuptake inhibition.

SSRI to SNRI Transition (Inadequate Serotonergic Response)

Switching from an SSRI to an SNRI (venlafaxine, duloxetine) adds norepinephrine reuptake inhibition to the serotonergic baseline. This is a medication change rather than true augmentation, but it documents the same clinical reality: single-mechanism treatment was insufficient.

Atypical Antipsychotic Augmentation

In treatment-resistant PTSD or depression, low-dose atypical antipsychotics (quetiapine 25-200 mg, aripiprazole 2-10 mg) may be added. These agents modulate dopaminergic and serotonergic pathways beyond what SSRIs/SNRIs can achieve. Their use documents severe, treatment-resistant psychiatric illness.

Mood Stabilizer Augmentation

Lamotrigine, valproate, or lithium may augment antidepressant therapy in patients with mood instability, emotional dysregulation, or treatment-resistant depression following trauma. Each represents a step beyond standard first-line treatment.

How Augmentation Supports Case Value

Each augmentation step in the medication record is a clinical event that documents:

1. Partial treatment response -- the first agent was not sufficient
2. Specific symptom persistence -- a defined symptom cluster required targeted treatment
3. Clinical complexity -- the psychiatric injury involves multiple interacting conditions
4. Treatment duration -- augmentation extends the medication timeline, documenting chronicity

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages. The MERIT report captures each medication addition, the clinical rationale, and the timing -- creating an objective narrative of treatment escalation that supports the severity of psychological injury claims.

Pharmacy Lien Coverage

LienScripts covers all augmentation medications -- buspirone, prazosin, trazodone, atypical antipsychotics, mood stabilizers, and all primary agents -- under a pharmacy lien at zero upfront cost. The financial burden of multi-agent psychiatric regimens is eliminated entirely.

Related Resources

• Antidepressant Guide for Pain and PTSD in PI
• Treatment-Resistant PTSD: Medication Options
• Polypharmacy in Psychiatric Medications After an Accident